Clinical trials
Angina, Stable trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CID - Carbostent & Implantable Devices | 2 |
| VZW Cardiovascular Research Center Aalst | 2 |
| Abbott Medical Devices | 1 |
| Ablynx, a Sanofi company | 1 |
| Antwerp Cardiovascular Institute Middelheim | 1 |
| CeloNova BioSciences, Inc. | 1 |
| Ceric Sàrl | 1 |
| M.A. Med Alliance S.A. | 1 |
| Maastricht University Medical Center | 1 |
| Shockwave Medical, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina, Stable | 15 |
| Angina, Unstable | 8 |
| Coronary Artery Disease | 7 |
| Angina Pectoris | 6 |
| Non-ST Elevated Myocardial Infarction | 3 |
| Acute Coronary Syndrome | 2 |
| Atherosclerosis | 2 |
| Angina Pectoris, Variant | 1 |
| Myocardial Infarction | 1 |
| Thoracic Diseases | 1 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.